80% of Houses Have This Issue | Dr. Scott McMahon & Dr. Ritchie Shoemaker | EP 415
19 Jan 2024 (8 months ago)
- Jordan Peterson announces his 2024 tour, visiting 51 cities in the US.
- The tour will cover ideas from his upcoming book, "We Who Wrestle with God," to be released in November 2024.
- Lead is a known neurotoxin, and its use in gasoline and wine sealing contributed to a decrease in IQ worldwide.
- Dr. Jordan Peterson introduces Dr. Richie Shoemaker and Dr. Scott McMahon, experts in chronic inflammatory response syndrome (CIRS).
- CIRS is linked to conditions like sick building syndrome, fibromyalgia, chronic fatigue syndrome, Alzheimer's, and other degenerative neurological conditions.
- Exposure to biotoxins in water-damaged buildings, especially those with anti-fungal paints, can trigger an immunological response with various neurological and behavioral consequences.
- The military faces a particular problem with low-grade military housing often suffering from water damage and mold infestation.
- Dr. Shoemaker explains CIRS and its widespread prevalence.
- Over 95% of CIRS patients have defective antigen processing, leading to reduced or absent antibody production.
- CIRS involves both inflammation and metabolic abnormalities, resulting in molecular hypometabolism in 95% of chronic fatigue patients.
- Genetic mechanisms underlie defective antigen presentation and inflammation, and therapies have been developed to correct gene activation and suppression.
- CIRS research aims to correct dieback central nervous system degeneration, including conditions like Alzheimer's, Parkinson's, and ALS.
- Dr. McMahon discusses the link between CIRS and living in water-damaged buildings.
- Inhalation of microbial growth from molds, bacteria, or actinobacteria triggers the innate immune system, leading to overproduction of cytokines and symptoms similar to the flu.
- Many buildings harbor airborne pathogens, with mold being the most common, especially in water-damaged buildings.
- Chronic exposure to these pathogens can trigger an immune response, leading to flu-like symptoms, pain, and chronic inflammation in susceptible individuals.
- The percentage of affected buildings in North America and worldwide is significant, with estimates ranging from 50% to 85% according to the United States Environmental Protection Agency (EPA).
- Water intrusion is a common factor in affected buildings.
- Natural selection favored molds and other biohazards that could tolerate exposure to antifungal chemicals in paints and sealants.
- As a result, these organisms became more toxic in order to survive, producing more potent toxins.
- Fungi respond to environmental hazards by activating genes that produce toxins for predation, not defense.
- Actino bacteria thrive in alkaline environments created by substances that kill fungi, changing the pH of drywall over time.
- Different groups of fungi and bacteria colonize water-damaged buildings at different stages, depending on the water saturation level.
- Certain architectural features make buildings more likely to become water damaged, such as flat roofs, basements, and crawl spaces.
- Drywall is more prone to problems compared to plaster on lathe.
- The widespread use of drywall in the latter half of the 20th century, combined with the use of fungicides in paints, has contributed to the contamination of a significant number of buildings.
- Individual susceptibility plays a crucial role in determining who gets sick from exposure to contaminated buildings.
- Studies have shown that around 95% of individuals with a specific immune response gene (HLA-DR) develop symptoms when exposed to contaminated environments.
- Long COVID and chronic inflammatory and metabolic response syndrome can be triggered by an initial priming event, such as COVID-19 infection, in individuals living in contaminated buildings.
- 75% of buildings are contaminated with pathogens that could produce an immune hyperresponse.
- 25% of the population in those buildings is particularly susceptible due to a genetic predisposition to immune overreaction.
- 20% of the population may be experiencing chronic inflammatory response syndrome (SIRS) as a serious problem.
- Many different illnesses have overlapping symptoms, making diagnosis difficult.
- Depression, fibromyalgia, chronic fatigue syndrome, and SIRS all have similar symptoms.
- Current diagnostic methods often misdiagnose these illnesses.
- SIRS can be distinguished from other illnesses by its specific biomarkers.
- SIRS has 30 biomarkers that can distinguish ill people from healthy people.
- The more biomarkers a person has, the less likely it is that the diagnosis is a false positive.
- The prime biomarkers for SIRS are:
- HLA (human leukocyte antigen)
- VCS (visual contrast sensitivity)
- MSH (melanoid stimulating hormone)
- Cytokindes
- TGF beta 1
- These biomarkers have been validated through research and clinical trials.
- CIRS can be tested using capillary blood cell speed.
- A visual contrast sensitivity test is used to test retinal acuity.
- Reduced flow of red blood cells in the retinal blood vessels and capillary beds is a sign of inflammation.
- Retinal flow can be measured objectively with a Heidelberg retinal flow meter.
- Treatment can improve flow and restore normal flow to equal controls.
- Reexposure to environmental triggers can cause the same findings to return.
- Retinal tissue is closely analogous to brain tissue.
- Retinal dysfunction may be linked to broader central nervous system dysfunction or brain dysfunction.
- The same mechanism of cytokine response in capillary beds occurs regardless of the trigger (e.g., fungus, bacteria, flu).
- Treatment can separate cytokines, but skeptics can be convinced by demonstrating that Voodoo medicine does not work while treatment does.
- Reinstating the illness after treatment with reexposure provides direct causality.
- People with CIRS may experience decreased red blood flow to different parts of the body, including the hands, feet, and brain.
- Reduced blood flow can lead to cold hands or feet, cramping, pain, and discoloration.
- Decreased blood flow to the brain can cause brain fog and potentially lead to cellular death and neurologic illnesses.
- Evaluating brain function involves assessing symptoms, biomarkers, and illnesses associated with toxin exposure.
- Fatigue and weakness
- Aching and cramping, especially in legs and hands
- Respiratory issues: cough, shortness of breath, sinus congestion
- Eye findings: red eyes, blurred vision, tearing, sensitivity to bright light
- Lung involvement: restricted lung disease, not obstructive
- Abdominal pain, secretory diarrhea, vomiting, nausea
- Joint problems: soreness, stiffness, especially in the morning and after sitting for long periods
- Cognitive issues: difficulty with memory, assimilation of new knowledge, concentration, and disorientation
- Changes in appetite, weight, sweats, and night sweats
- Visual Contrast Sensitivity (VCS) test
- Symptom analysis and symptom clusters
- Factor analysis of symptoms
- Chronic fatigue syndrome (CFS)
- Fibromyalgia
- Multiple chemical sensitivity (MCS)
- Post-traumatic stress disorder (PTSD)
- Gulf War syndrome
- Autism
- Attention Deficit Hyperactivity Disorder (ADHD)
- Depression
- Anxiety
- Bipolar disorder
- Schizophrenia
- CIRS may be associated with a higher risk of Alzheimer's in Finland due to architectural designs that make houses more susceptible to biotoxins.
- CIRS symptoms can be detected decades before Alzheimer's develops, as seen in studies of nuns' writing samples.
- Verbal fluency tests may be useful markers for cognitive interference in CIRS.
- CIRS can cause various neurological degenerative conditions, including tremors, metallic taste, dizziness, vertigo, and cognitive deficits.
- Neuroquant, a brain imaging technique, can detect abnormalities in CIRS patients and can be used to monitor treatment progress.
- Different patterns of brain damage are associated with CIRS caused by water-damaged buildings (enlarged forebrain parenchyma, enlarged cortical gray matter, and atrophied caudate nucleus) and Lyme disease (enlarged putamen and atrophied caudate nucleus).
- VIP (vasoactive intestinal polypeptide) therapy has been shown to stop or reverse caudate nucleus and multinuclear atrophy in CIRS patients.
- Treatment for CIRS involves:
- Identifying and eliminating exposure to the source of biotoxins (e.g., water-damaged buildings).
- Using binders such as cholestyramine or Welchol to remove biotoxins from the body.
- Following Dr. Shoemaker's protocol, which involves a series of steps to address different systems of inflammation.
- Considering intranasal VIP therapy if symptoms do not improve after the above steps.
- Intensification: worsening of symptoms when starting binder treatment.
- Pre-treatment with compounds that reduce inflammatory response (e.g., Omega-3 fatty acids) can reduce intensification.
- For people with marchons or Lyme disease, low-dose VIP can be used as the first step to reduce intensification.
- CIRS can make travel and visiting others more difficult due to sensitivity to toxins.
- Recovery from CIRS and maintaining a clean environment can help reduce susceptibility to relapse.
- Medications can be taken on a prophylactic basis to reduce the risk of relapse when traveling or in high-risk environments.
- Leptin resistance, associated with obesity, can lead to decreased production of MSH, resulting in fatigue, pain, and weight gain.
- CIRS can contribute to obesity through molecular hypometabolism and weight storage mechanisms.
- Research has found that activating brown fat and increasing energy consumption can help combat weight storage and fat storage.
- The researchers presented their findings to the House and Senate Armed Services Committee, resulting in a $300 million appropriation for investigating military housing.
- The report highlighted the presence of mold and infestations in military housing, potentially affecting troop readiness and the mental and physical health of service members and their families.
- Misdiagnosis of CIRS can lead to attributing physiological alterations to psychological conditions.
- Depression and anxiety, common symptoms of CIRS, can be mistaken for psychological factors, overlooking the underlying physiological causes.
- It's important to consider CIRS as a potential cause of chronic headaches and abdominal pains in children and adults.
- CIRS is prevalent in children with chronic headaches and abdominal pains.
- Evaluation for CIRS and appropriate treatment can significantly reduce or eliminate these symptoms in children.
- CIRS is often overlooked as a cause of chronic stomach pains in adults, but testing for CIRS biomarkers can lead to effective treatment.
- 25% of people are susceptible to CIRS due to physiological and genetic reasons.
- Genetic markers can indicate susceptibility to CIRS.
- Ribosomes, the structures that make proteins, can be affected by toxins, leading to impaired protein production and cell dysfunction.
- Mitochondrial dysfunction occurs, with glucose being broken down into lactic acid instead of being used for energy production.
- Metabolic acidosis, lack of regulatory T cells, gray matter nuclear atrophy, pulmonary hypertension, obesity, and insulin resistance are complications of metabolic abnormalities.
- Insulin receptor substrate 2 (IRS2) can affect glucose uptake and metabolism, impacting the effectiveness of diets like the keto diet and the carnivore diet.
- Defective apoptosis (programmed cell death) leads to an increased antigen load in the bloodstream, contributing to inflammation.
- Genetic markers associated with defective apoptosis, such as RPK1, can indicate an endogenous source of CIRS.
- Upregulation of coagulation factors can bind to TA and T beta in the brain, creating microclots and contributing to Alzheimer's disease.
- Increased cytokines and specific markers for endotoxins, such as TGFBR1 and MAP3K8, indicate actinobacteria injury.
- Susceptibility to Alzheimer's disease is separate from CIRS susceptibility.
- Genetic markers associated with microtubule disruption, such as TUBA4A and DUB1, are linked to dieback neuropathy and cognitive impairment.
- Coagulation abnormalities and vascular phenomena contribute to cognitive decline in Alzheimer's disease.
- Energy flow abnormalities and blood flow abnormalities can be identified in CIRS patients.